ISO/TS 5798:2022

In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods

Publication date: Apr 19, 2022

General information

Current stage: 60.60 Effective date: Apr 19, 2022

Originator: ISO

Owner: ISO/TC 212

Type: Technical Specification

ICS: 11.100.01

Languages: English French

Buying

Status: Published

PDF - EC$499.66

Paper - EC$499.66

PDF and Paper - EC$999.32

Language

Language in which you want to receive the document.

Scope

This document provides requirements and recommendations for the design, development, verification, validation and implementation of analytical tests for detecting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using nucleic acid amplification. It addresses pre-examination, examination and post-examination process steps for human specimens.
This document is applicable to medical laboratories. It is also intended to be used by in vitro diagnostic developers and manufacturers, as well as by institutions and organizations supporting SARS-CoV-2 research and diagnostics.
This document does not apply to environmental samples.

Life cycle

NOW

PUBLISHED
ISO/TS 5798:2022
60.60 Standard published
Apr 19, 2022

Preview

Only informative sections of projects are publicly available. To view the full content, you will need to members of the committee. If you are a member, please log in to your account by clicking on the "Log in" button.